EVITA TEST COMPLETE and EVITA TEST GENDER are developed by the Danish biotech company ARCEDI Biotech in close collaboration with Aarhus University Hospital. Since 2007 a dedicated research team at ARCEDI, together with Aarhus University Hospital and some other hospitals in Denmarks, has worked to develop cell-based NIPT.

A dedicated research team
Since 2007, ARCEDI, together with Aarhus University Hospital and some other hospitals in Denmark, have worked to develop cell-based Non-Invasive Prenatal Test (cbNIPT) by isolating rare fetal cells from the blood samples from pregnant women. This pioneering work has lead to the development of technology behind EVITA TEST COMPLETE.

In has been known for many decades that during pregnancy fetal cells do end up into maternal blood circulation. If isolated and analyzed they can be an excellent source to perform high resolution NIPT. However, rarity of these cells in pregnant women’s blood has hindered the development of a reliable technology for performing cell-based NIPT.

The perseverance of ARCEDI’s scientists lead to the development of patented and robust technology of isolating and analyzing these fetal cells.

A unique product
EVITA TEST COMPLETE is a revolution for pregnant couples who want to know about their unborn child’s chromosomes. The test is based on a blood sample – and is thus completely without the risk to the baby and with minimal discomfort to the pregnant woman. EVITA TEST COMPLETE differs from other non-invasive prenatal tests (NIPT) as it gives a result for all fetal chromosomes. We are proud of our product, which can do more than the conventional NIPT and unlike the CVS, is completely risk-free for the fetus. 

An aim to make a difference
Technological advancements have contributed significantly to the development of EVITA TEST COMPLETE, but ARCEDI’s team is driven by their product and its prospects. Our goal regarding EVITA TEST COMPLETE is to provide as many couples and pregnant women around the world as possible with a safe pregnancy, knowing about their future child’s chromosomes without risky and uncomfortable invasive procedures.

ARCEDI collaborates with some of Denmark’s most skilled genetic experts, and with analysis results based on intact fetal cells, we provide them with the best possible conditions to assess the fetus’s chromosomal profile without the use of invasive diagnostics.

Arcedi Evita Test laboratorie

An ambition to open new doors
ARCEDI´s patented technology has the potential to make a noticeable difference and analyze fetuses for many other serious diseases. It is in our DNA to continue our research, and achieve new goals to provide security and certainty in pregnancy to as many people as possible.

If you want to know more about ARCEDI, you can see more on ARCEDI’s website.


ARCEDI has two offices in Denmark:

Tabletvej 1
DK-7100 Vejle

INCUBA, Palle Juul-Jensens Boulevard 82 DK-8200 Aarhus N

For additional information:

Lotte Hatt, Chief Scientific Officer 
Mail: loha@arcedi.com 
Phone: +45 61 71 25 57